CAL-101, A p110delta Selective Phosphatidylinositol-3-Kinase Inhibitor for the Treatment of B-cell Malignancies, Inhibits PI3K Signaling and Cellular Viability

Flow CAST® – Kinase Inhibition Assay Citation:

Lannutti, B.J. et al. CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood. 2011 Jan 13; 117(2): 591-594.

PMID: 20959606.

“We have thus described the biochemical and cellular activity of CAL-101, a selective and potent inhibitor of p110δ; such targeted inhibition has the potential to avoid adverse effects that may result from nonselective PI3K inhibition.”